Hemmings HC.
2004.
Neuroprotection by Na+ channel blockade.. J Neurosurg Anesthesiol. 16(1):100-1.
Hemmings HC.
1998.
General anesthetic effects on protein kinase C.. Toxicol Lett. 100-101:89-95.
Hemmings HC, Nairn AC, Greengard P.
1986.
Protein kinases and phosphoproteins in the nervous system.. Res Publ Assoc Res Nerv Ment Dis. 64:47-69.
Hemmings HC, Akabas MH, Goldstein PA, Trudell JR, Orser BA, Harrison NL.
2005.
Emerging molecular mechanisms of general anesthetic action.. Trends Pharmacol Sci. 26(10):503-10.
Hemmings HC, Greengard P.
1986.
DARPP-32, a dopamine-regulated phosphoprotein.. Prog Brain Res. 69:149-59.
Hemmings HC, Greengard P.
2010.
Positively active: how local anesthetics work.. Anesthesiology. 113(1):250-2.
Hemmings HC, Mantz J.
2008.
Xenon and the pharmacology of fear.. Anesthesiology. 109(6):954-5.
Hemmings HC, Yan W, Westphalen RI, Ryan TA.
2005.
The general anesthetic isoflurane depresses synaptic vesicle exocytosis.. Mol Pharmacol. 67(5):1591-9.
Herold KF, R Sanford L, Lee W, Schultz MF, Ingólfsson HI, Andersen OS, Hemmings HC.
2014.
Volatile anesthetics inhibit sodium channels without altering bulk lipid bilayer properties.. J Gen Physiol. 144(6):545-60.